🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 8454972

    Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8450055

    Malaria antigen screening method

    United States of America as represented by the Secretary of the Air Force · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8450345

    Iminosugars and methods of treating viral diseases

    United Therapeutics Corporation · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8449875

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8449877

    Pharmaceutically purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8444996

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8445658

    Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8440208

    Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8440813

    Antiviral nucleoside analogs

    BioCryst Pharmaceuticals, Inc. · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8426445

    Iminosugars and methods of treating bunyaviral and togaviral diseases

    United Therapeutics Corporation · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    UNIVERSITY OF CONNECTICUT · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8426458

    Hepatitis C Virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8420099

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8420686

    Linked diimidazole antivirals

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8420596

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8415323

    MicroRNAs for inhibiting viral replication

    The Regents of the University of California · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8410073

    Methods and compositions for prevention or treatment of RSV infection

    Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8399428

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8389231

    Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8383583

    Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8383785

    Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8383133

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8377872

    Cyclic P3 tripeptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8367401

    Replication competent hepatitis C virus and methods of use

    The Board of Regents of the University of Texas System · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8367618

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8361982

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8361756

    Bifidobacterial gene sequences and their use

    The Regents of the University of California · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8361707

    Methods for detecting a Mycobacterium tuberculosis infection

    The United States of America—Department of Veterans Affairs · Granted Tue Jan 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8357718

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8354419

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8349586

    Commensal strain of E. coli encoding an HIV GP41 protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8350042

    Antiviral compounds for the treatment of HCV infection

    The Regents of the University of California · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8337866

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    The Regents of the University of California · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8329664

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8329924

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8323662

    Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

    IMMUNE DESIGN CORP. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8318177

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8318425

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8318182

    Vault compositions for immunization against Chlamydia genital infection

    The Regents of the University of California · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8314141

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8314135

    Linked dibenzimidazole antivirals

    Enanta Pharmaceuticals, Inc. · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8309071

    Foamy viral envelope genes

    Vectoria Forschungsforderungs Verein E.V. · Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8309355

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8304385

    Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8288439

    Methods and compositions for the inhibition of HIV-1 replication

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.